AMN HEALTHCARE SERVICES INC (AMN) Fundamental Analysis & Valuation

NYSE:AMN • US0017441017

Current stock price

18.31 USD
+0.38 (+2.12%)
At close:
18.31 USD
0 (0%)
After Hours:

This AMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. AMN Profitability Analysis

1.1 Basic Checks

  • In the past year AMN was profitable.
  • AMN had a positive operating cash flow in the past year.
  • In multiple years AMN reported negative net income over the last 5 years.
  • Each year in the past 5 years AMN had a positive operating cash flow.
AMN Yearly Net Income VS EBIT VS OCF VS FCFAMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • AMN's Return On Assets of -4.57% is on the low side compared to the rest of the industry. AMN is outperformed by 67.33% of its industry peers.
  • AMN's Return On Equity of -14.90% is on the low side compared to the rest of the industry. AMN is outperformed by 62.38% of its industry peers.
  • AMN's Return On Invested Capital of 1.73% is in line compared to the rest of the industry. AMN outperforms 40.59% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for AMN is below the industry average of 8.92%.
  • The last Return On Invested Capital (1.73%) for AMN is well below the 3 year average (6.19%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
Industry RankSector Rank
ROA -4.57%
ROE -14.9%
ROIC 1.73%
ROA(3y)-1.15%
ROA(5y)4.48%
ROE(3y)-3.45%
ROE(5y)12.07%
ROIC(3y)6.19%
ROIC(5y)12.47%
AMN Yearly ROA, ROE, ROICAMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • Looking at the Operating Margin, with a value of 1.21%, AMN is in line with its industry, outperforming 40.59% of the companies in the same industry.
  • AMN's Operating Margin has declined in the last couple of years.
  • AMN has a Gross Margin of 28.35%. This is comparable to the rest of the industry: AMN outperforms 55.45% of its industry peers.
  • AMN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.21%
PM (TTM) N/A
GM 28.35%
OM growth 3Y-53.83%
OM growth 5Y-32.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-3.04%
AMN Yearly Profit, Operating, Gross MarginsAMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. AMN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMN is destroying value.
  • The number of shares outstanding for AMN has been increased compared to 1 year ago.
  • Compared to 5 years ago, AMN has less shares outstanding
  • Compared to 1 year ago, AMN has an improved debt to assets ratio.
AMN Yearly Shares OutstandingAMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AMN Yearly Total Debt VS Total AssetsAMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • AMN has an Altman-Z score of 2.43. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • AMN has a Altman-Z score (2.43) which is in line with its industry peers.
  • The Debt to FCF ratio of AMN is 3.28, which is a good value as it means it would take AMN, 3.28 years of fcf income to pay off all of its debts.
  • AMN has a Debt to FCF ratio of 3.28. This is in the better half of the industry: AMN outperforms 71.29% of its industry peers.
  • AMN has a Debt/Equity ratio of 1.19. This is a high value indicating a heavy dependency on external financing.
  • AMN has a Debt to Equity ratio of 1.19. This is in the lower half of the industry: AMN underperforms 63.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 3.28
Altman-Z 2.43
ROIC/WACC0.22
WACC7.72%
AMN Yearly LT Debt VS Equity VS FCFAMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • AMN has a Current Ratio of 0.94. This is a bad value and indicates that AMN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AMN has a worse Current ratio (0.94) than 75.25% of its industry peers.
  • AMN has a Quick Ratio of 0.94. This is a bad value and indicates that AMN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.94, AMN is not doing good in the industry: 69.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.94
AMN Yearly Current Assets VS Current LiabilitesAMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AMN Growth Analysis

3.1 Past

  • AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.91%.
  • Measured over the past years, AMN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.94% on average per year.
  • AMN shows a decrease in Revenue. In the last year, the revenue decreased by -8.49%.
  • Measured over the past years, AMN shows a small growth in Revenue. The Revenue has been growing by 2.67% on average per year.
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
Revenue 1Y (TTM)-8.49%
Revenue growth 3Y-19.55%
Revenue growth 5Y2.67%
Sales Q2Q%1.84%

3.2 Future

  • AMN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.37% yearly.
  • AMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.67% yearly.
EPS Next Y36.65%
EPS Next 2Y-8.75%
EPS Next 3Y-7.38%
EPS Next 5Y52.37%
Revenue Next Year17.16%
Revenue Next 2Y-0.37%
Revenue Next 3Y1.06%
Revenue Next 5Y7.67%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AMN Yearly Revenue VS EstimatesAMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
AMN Yearly EPS VS EstimatesAMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

7

4. AMN Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 13.46, AMN is valued correctly.
  • Based on the Price/Earnings ratio, AMN is valued cheaper than 86.14% of the companies in the same industry.
  • AMN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.73.
  • Based on the Price/Forward Earnings ratio of 9.85, the valuation of AMN can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, AMN is valued cheaply inside the industry as 91.09% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of AMN to the average of the S&P500 Index (23.72), we can say AMN is valued rather cheaply.
Industry RankSector Rank
PE 13.46
Fwd PE 9.85
AMN Price Earnings VS Forward Price EarningsAMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 81.19% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
  • AMN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMN is cheaper than 98.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.03
EV/EBITDA 7.51
AMN Per share dataAMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • AMN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AMN's earnings are expected to decrease with -7.38% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y-8.75%
EPS Next 3Y-7.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AMN Dividend Analysis

5.1 Amount

  • AMN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMN Fundamentals: All Metrics, Ratios and Statistics

AMN HEALTHCARE SERVICES INC

NYSE:AMN (3/19/2026, 8:04:00 PM)

After market: 18.31 0 (0%)

18.31

+0.38 (+2.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)05-06
Inst Owners103.39%
Inst Owner Change-1.08%
Ins Owners0.38%
Ins Owner Change8.99%
Market Cap707.50M
Revenue(TTM)2.73B
Net Income(TTM)-95.70M
Analysts69.23
Price Target22.66 (23.76%)
Short Float %5.68%
Short Ratio1.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)35.78%
Min EPS beat(2)-21.51%
Max EPS beat(2)93.07%
EPS beat(4)3
Avg EPS beat(4)60.31%
Min EPS beat(4)-21.51%
Max EPS beat(4)116.02%
EPS beat(8)7
Avg EPS beat(8)40.9%
EPS beat(12)11
Avg EPS beat(12)30.43%
EPS beat(16)15
Avg EPS beat(16)25.36%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.64%
Max Revenue beat(2)2.36%
Revenue beat(4)3
Avg Revenue beat(4)1.46%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)2.36%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)7
Avg Revenue beat(12)0.85%
Revenue beat(16)11
Avg Revenue beat(16)1.44%
PT rev (1m)6.51%
PT rev (3m)7.24%
EPS NQ rev (1m)1320.88%
EPS NQ rev (3m)1232.99%
EPS NY rev (1m)172.37%
EPS NY rev (3m)140.7%
Revenue NQ rev (1m)94.61%
Revenue NQ rev (3m)94.31%
Revenue NY rev (1m)24.16%
Revenue NY rev (3m)24.01%
Valuation
Industry RankSector Rank
PE 13.46
Fwd PE 9.85
P/S 0.26
P/FCF 3.03
P/OCF 2.63
P/B 1.1
P/tB N/A
EV/EBITDA 7.51
EPS(TTM)1.36
EY7.43%
EPS(NY)1.86
Fwd EY10.15%
FCF(TTM)6.05
FCFY33.05%
OCF(TTM)6.97
OCFY38.09%
SpS70.66
BVpS16.62
TBVpS-10.28
PEG (NY)0.37
PEG (5Y)N/A
Graham Number22.55
Profitability
Industry RankSector Rank
ROA -4.57%
ROE -14.9%
ROCE 2.19%
ROIC 1.73%
ROICexc 1.77%
ROICexgc 5.91%
OM 1.21%
PM (TTM) N/A
GM 28.35%
FCFM 8.56%
ROA(3y)-1.15%
ROA(5y)4.48%
ROE(3y)-3.45%
ROE(5y)12.07%
ROIC(3y)6.19%
ROIC(5y)12.47%
ROICexc(3y)6.27%
ROICexc(5y)13.02%
ROICexgc(3y)21.12%
ROICexgc(5y)45.11%
ROCE(3y)7.84%
ROCE(5y)15.78%
ROICexgc growth 3Y-59.99%
ROICexgc growth 5Y-29.62%
ROICexc growth 3Y-59.19%
ROICexc growth 5Y-26.95%
OM growth 3Y-53.83%
OM growth 5Y-32.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-3.04%
F-Score5
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 3.28
Debt/EBITDA 4.04
Cap/Depr 22.75%
Cap/Sales 1.3%
Interest Coverage 0.74
Cash Conversion 141.99%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.94
Altman-Z 2.43
F-Score5
WACC7.72%
ROIC/WACC0.22
Cap/Depr(3y)44.93%
Cap/Depr(5y)49.12%
Cap/Sales(3y)2.27%
Cap/Sales(5y)1.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
EPS Next Y36.65%
EPS Next 2Y-8.75%
EPS Next 3Y-7.38%
EPS Next 5Y52.37%
Revenue 1Y (TTM)-8.49%
Revenue growth 3Y-19.55%
Revenue growth 5Y2.67%
Sales Q2Q%1.84%
Revenue Next Year17.16%
Revenue Next 2Y-0.37%
Revenue Next 3Y1.06%
Revenue Next 5Y7.67%
EBIT growth 1Y-72.31%
EBIT growth 3Y-62.85%
EBIT growth 5Y-30.5%
EBIT Next Year231.17%
EBIT Next 3Y39.54%
EBIT Next 5YN/A
FCF growth 1Y-2.38%
FCF growth 3Y-25.82%
FCF growth 5Y1.44%
OCF growth 1Y-15.9%
OCF growth 3Y-25.58%
OCF growth 5Y0.97%

AMN HEALTHCARE SERVICES INC / AMN Fundamental Analysis FAQ

What is the fundamental rating for AMN stock?

ChartMill assigns a fundamental rating of 4 / 10 to AMN.


Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?

ChartMill assigns a valuation rating of 7 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Undervalued.


How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?

AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 3 / 10.


What is the earnings growth outlook for AMN HEALTHCARE SERVICES INC?

The Earnings per Share (EPS) of AMN HEALTHCARE SERVICES INC (AMN) is expected to grow by 36.65% in the next year.